Search

866-361-3032

Dec. 7 - FDA Seeks Input on Communication of Drug Safety Information

Posted Date: 
Wednesday, December 7, 2005

As part of the Food and Drug Administration's continued commitment to improve communication about risks posed by prescription medications, its Center for Drug Evaluation and Research (CDER) is holding a public meeting today to evaluate current practices and to explore new tools and strategic partnerships to enhance future efforts.

"In the past year we have made significant strides in alerting healthcare professionals and their patients of emerging risks associated with prescription medications," said Andrew von Eschenbach, MD, Acting FDA Commissioner. "We intend to use the public feedback we receive at this meeting to advance our understanding of the effectiveness of our current efforts and to develop new tools to hone our ability to inform the public."

Source

Testimonial

Faced with a tight customer deadline for one of our key growth products, DSC turned to Nexreg for converting our MSDS to an EU French language SDS. Within a very short time frame, Nexreg staff provided a competitive quote and turnaround time. With the technical support of highly professional and responsive Nexreg consultants we were able to provide our customer with a compliant SDS that supported their downstream manufacturing needs. Thank you Nexreg!
Mike Horvath, Ph.D., Digital Specialty Chemicals Ltd